HighTower Advisors, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 50 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$283,000
+1.8%
27,6880.0%0.00%0.0%
Q4 2022$278,000
-93.2%
27,688
-93.3%
0.00%
-90.9%
Q3 2022$4,086,000
-13.9%
415,388
-14.8%
0.01%
-8.3%
Q2 2022$4,746,000
-0.5%
487,388
-0.5%
0.01%
+9.1%
Q1 2022$4,771,000
-14.9%
489,788
-15.6%
0.01%
-8.3%
Q4 2021$5,609,000
-1.8%
580,138
-1.9%
0.01%
-20.0%
Q3 2021$5,713,000591,2880.02%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2023
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 141,317$1,448,4992.02%
Atalaya Capital Management LP 500,000$5,115,0001.63%
MMCAP International Inc. SPC 800,000$8,184,0001.61%
ANGELO GORDON & CO., L.P. 300,000$3,069,0000.77%
FIR TREE CAPITAL MANAGEMENT LP 792,269$8,104,9120.64%
Castle Creek Arbitrage, LLC 530,000$5,421,9000.60%
683 Capital Management, LLC 699,000$7,150,7700.53%
GLAZER CAPITAL, LLC 850,590$8,7020.48%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$5,125,0000.45%
METEORA CAPITAL, LLC 366,183$3,746,0520.44%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders